SPY425.26+0.95 0.22%
DIA344.30-0.82 -0.24%
IXIC14,174.14+104.72 0.74%

Takeda Pharmaceutical Posts Higher Fiscal 2020 Core EPS, Revenue Declines

05/11/2021 04:09

08:00 AM EDT, 05/11/2021 (MT Newswires) -- Takeda Pharmaceutical Co. (TAK) on Tuesday reported fiscal 2020 core earnings of 420 Japanese yen ($3.84) per share, up from 387 yen per share a year earlier.

Revenue was 3.2 billion yen for the fiscal year ended March 31, down from 3.29 billion yen a year ago.

For fiscal 2021, the company expects mid-single-digit growth in revenue and core EPS. The projected core EPS for the fiscal year is 394 yen, while revenue is expected to be 3.37 billion.

Price: 16.93, Change: -0.03, Percent Change: -0.18